PSILAdvisorShares Psychedelics ETF
PSIL Fund Description
PSIL is actively managed to provide exposure to the emerging global psychedelics industry.
PSIL Factset Analytics Insight
PSIL is an actively-managed portfolio of publicly-listed companies that derive at least 50% of their revenue or devote 50% of their assets to legal activities related to psychedelic medicines and their derivatives, excluding cannabis. It invests in stocks of US and foreign mid-, small-, and micro-cap firms and in swaps that provide the same exposure. PSIL aims to concentrate at least 25% of its investments in the Pharmaceuticals, Biotechnology & Life Sciences industry group. The fund adviser uses outside analyst ratings and stock selection rating tools to select companies that dominate their respective industries or are in unique positions for growth and expansion. Additionally, the fund has the ability to engage in stock lending, up to 33.3% of the portfolio, in order to increase income to the issuer.
PSIL Summary Data
PSIL Portfolio Data
PSIL Index Data
PSIL Portfolio Management
PSIL Tax Exposures
PSIL Fund Structure
PSIL Factset Analytics Block Liquidity
This measurement shows how easy it is to trade a $1 million USD block of PSIL. PSIL is rated a N/A out of 5.
PSIL Top 10 Holdings[View All]
PSIL Performance Statistics
PSIL Benchmark Comparison Summary
PSIL Benchmark Comparison Market Cap Size